Search alternatives:
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
-
8841
-
8842
Predicted protein sequence for CRISPR generated <i>syt7a</i> mutant alleles.
Published 2024Subjects: -
8843
<i>syt7a</i> mutant larvae do not exhibit altered behavioral phenotype at 6 days post fertilization.
Published 2024Subjects: -
8844
-
8845
-
8846
Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus.
Published 2023Subjects: -
8847
-
8848
-
8849
Binding of neuraminidase inhibitory antibodies to cells expressing 245 NA Gly+/- proteins.
Published 2020Subjects: -
8850
-
8851
-
8852
-
8853
CRISPR-Cas9 generated <i>syt7a</i> mutant alleles complement the <i>escapist p404</i> mutation.
Published 2024Subjects: -
8854
-
8855
-
8856
Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ.
Published 2023Subjects: -
8857
Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice.
Published 2023Subjects: -
8858
-
8859
-
8860
The abundance of core fucosylation and bisecting modification in N-glycan and glycoprotein levels.
Published 2015“…<p>The abundance of core fucosylation and bisecting modification in N-glycan and glycoprotein levels were illustrated using DSA-FACE and serum lectin blot. (A) and (B): The abundance of total core fucosylation residues (the sum of Peak1, 2, 3, 4, 6, 7 and Peak10) from DSA-FACE decreased in LCMM patients (n = 42) than that in healthy controls (n = 42), and decreased according to the severity of the disease [moderate LCMM (n = 14) and severe LCMM (n = 28)]. …”